Optus Pharmaceutical Co Ltd
KOSDAQ:131030
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| KR |
O
|
Optus Pharmaceutical Co Ltd
KOSDAQ:131030
|
181.1B KRW |
Loading...
|
|
| JP |
|
Hoya Corp
TSE:7741
|
9.4T JPY |
Loading...
|
|
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
55.4B USD |
Loading...
|
|
| CH |
|
Alcon AG
SIX:ALC
|
29.7B CHF |
Loading...
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
102.6B DKK |
Loading...
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.6B USD |
Loading...
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.6B GBP |
Loading...
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
40.8B CNY |
Loading...
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.9B USD |
Loading...
|
|
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
38.2B CNY |
Loading...
|
|
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
828.9B JPY |
Loading...
|
Market Distribution
| Min | -646.5% |
| 30th Percentile | 12.8% |
| Median | 19.7% |
| 70th Percentile | 32.2% |
| Max | 54 001.3% |
Other Profitability Ratios
Optus Pharmaceutical Co Ltd
Glance View
OPTUS Pharmaceutical Co., Ltd. engages in the manufacture and sale of ophthalmic products. The company is headquartered in Cheongju, Chungcheongbuk-Do and currently employs 171 full-time employees. The company went IPO on 2010-12-03. The firm is primarily engaged in the manufacture and sale of eye drops and ophthalmic preparations such as dry eye treatment agents, conjunctivitis treatment agents, anti-inflammatory medication agents, glaucoma treatment agents and others.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Optus Pharmaceutical Co Ltd is 55.8%, which is above its 3-year median of 55.7%.
Over the last 3 years, Optus Pharmaceutical Co Ltd’s Gross Margin has decreased from 56.6% to 55.8%. During this period, it reached a low of 53.6% on Mar 31, 2023 and a high of 57.2% on Dec 31, 2023.
